Infusional 5-fluorouracil and cisplatin as first-line chemotherapy in patients with carcinoma of unknown primary site

By  

Medical Oncology, Vol. 24, Iss. 2, 2007-06 ,pp. : 259-264

Humana Press, Inc

Access to resources Recommend Favorite

Epirubicin, Cisplatin, and Prolonged or Brief Infusional 5-Fluorouracil in the Treatment of Carcinoma of Unknown Primary Site

By Karapetis C.S.   Yip D.   Virik K.   Strickland A.   Ryder K.   Cowling M.   Harper P.G.  

Medical Oncology, Vol. 18, Iss. 1, 2001-03 ,pp. : 23-32

Humana Press, Inc

Access to resources Recommend Favorite

A phase II study to evaluate the efficacy and toxicity of oxaliplatin in combination with gemcitabine in carcinoma of unknown primary

By Carlson Heather  

International Journal of Clinical Oncology, Vol. 18, Iss. 2, 2013-04 ,pp. : 226-231

Springer Publishing Company

Access to resources Recommend Favorite

A Phase II Study of Gemcitabine and Cisplatin in Patients with Advanced, Persistent, or Recurrent Squamous Cell Carcinoma of the Cervix

By Burnett A.F.   Roman L.D.   Garcia A.A.   Muderspach L.I.   Brader K.R.   Morrow C.P.  

Gynecologic Oncology, Vol. 76, Iss. 1, 2000-01 ,pp. : 63-66

Elsevier

Access to resources Recommend Favorite

Surgically Documented Responses to Paclitaxel and Cisplatin in Patients with Primary Peritoneal Carcinoma

By Menzin A.W.   Aikins Jr J.K.   Wheeler J.E.   Rubin S.C.  

Gynecologic Oncology, Vol. 62, Iss. 1, 1996-07 ,pp. : 55-58

Academic Press

Access to resources Recommend Favorite